Monitoring environmental factors affecting skin diseases using non-invasive methods
Official title: Exposome Monitoring for Skin Diseases through Liquid Biopsy Multiomics
Funded at University of California, San Francisco · NIH-11080629 · Data updated 2026-11-12
This study is looking at how things in our environment affect skin conditions like psoriasis and atopic dermatitis, and it’s designed for patients who want to better understand their skin health by tracking changes in real-time from home.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 20, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $105,449 |
| NIH project number | 3R21AR084041-01S1 |
| Project ID | NIH-11080629 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with psoriasis or atopic dermatitis who are interested in monitoring their condition in relation to environmental factors.
✕Less likely to help
Patients with skin conditions unrelated to environmental factors or those who do not have psoriasis or atopic dermatitis may not benefit from this research.
What this research studies
This research investigates how environmental factors influence skin diseases like psoriasis and atopic dermatitis. It employs non-invasive methods to collect biosamples from patients and utilizes bioinformatics and machine learning to analyze changes in their skin. By developing remote monitoring technologies, the study aims to enhance our understanding of the immune responses in these conditions and facilitate home-based research. Patients will be engaged in a way that allows for real-time tracking of their skin health in relation to environmental exposures.
Why it matters
Potential benefit: If successful, this research could lead to improved management and treatment strategies for patients with skin diseases by identifying environmental triggers.
How similar studies have gone: Previous research has shown promise in using remote monitoring and machine learning approaches to understand skin diseases, indicating that this approach could be effective.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Liao, Wilson — University of California, San Francisco
- Study coordinator: Liao, Wilson
Related research
Other NIH-funded projects on the same topics.
-
Towards a blood-based test using nanophotonic exosomes to screen and diagnose liver cancer
A new blood test using tiny particles shed by liver cancer cells aims to screen for hepatocellular carcinoma earlier and more accurately.
-
Liquid biopsy test to screen for lymphoma in people with HIV
A new blood test called High Density Methyl-Seq is being checked to see if it can detect lymphoma early in people living with HIV.
-
Wearable optical biomarkers to diagnose and manage inflammatory skin diseases
This grant supports a clinician-scientist to develop wearable optical sensors and AI tools that help diagnose and manage inflammatory skin conditions like allergic contact dermatitis.
-
Liquid biopsy and oxygen therapy to guide glioblastoma treatment
A patient-focused study exploring a blood-based test and a safe oxygen therapy to help doctors tell true tumor growth from treatment effects in adults with glioblastoma treated with chemoradiation.
-
Liquid biopsy to monitor LMS treatment and resistance
A patient-centered look at using blood tests to see how well LMS treatment is working and when resistance to therapy appears.
-
Imagnostix: a simple blood-based test to flag Alzheimer’s risk
A new blood-based test called Imagnostix aims to help identify people who may be developing Alzheimer’s disease earlier and more cheaply than current methods.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.